BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1541878)

  • 1. Importance of establishing appropriate local reference values for the screening of hemochromatosis: a study of three different control populations and 136 hemochromatosis family members. Hemochromatosis Clinical and Research Group.
    Porto G; Vicente C; Fraga J; da Silva BM; de Sousa M
    J Lab Clin Med; 1992 Mar; 119(3):295-305. PubMed ID: 1541878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for hemochromatosis in asymptomatic subjects with or without a family history.
    Powell LW; Dixon JL; Ramm GA; Purdie DM; Lincoln DJ; Anderson GJ; Subramaniam VN; Hewett DG; Searle JW; Fletcher LM; Crawford DH; Rodgers H; Allen KJ; Cavanaugh JA; Bassett ML
    Arch Intern Med; 2006 Feb; 166(3):294-301. PubMed ID: 16476869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis.
    Bulaj ZJ; Griffen LM; Jorde LB; Edwards CQ; Kushner JP
    N Engl J Med; 1996 Dec; 335(24):1799-805. PubMed ID: 8943161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of hemochromatosis in young subjects: predictive accuracy of biochemical screening tests.
    Bassett ML; Halliday JW; Ferris RA; Powell LW
    Gastroenterology; 1984 Sep; 87(3):628-33. PubMed ID: 6745616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for hemochromatosis in children of homozygotes: prevalence and cost-effectiveness.
    Adams PC; Kertesz AE; Valberg LS
    Hepatology; 1995 Dec; 22(6):1720-7. PubMed ID: 7489980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors.
    Edwards CQ; Griffen LM; Goldgar D; Drummond C; Skolnick MH; Kushner JP
    N Engl J Med; 1988 May; 318(21):1355-62. PubMed ID: 3367936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary hemochromatosis. Phenotypic expression of the disease.
    Cartwright GE; Edwards CQ; Kravitz K; Skolnick M; Amos DB; Johnson A; Buskjaer L
    N Engl J Med; 1979 Jul; 301(4):175-9. PubMed ID: 449974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between genotype, assessed by HLA typing, and phenotypic expression of iron status markers in families of 29 probands with hereditary haemochromatosis.
    Milman N; Fenger K; Graudal NA; Nielsen LS
    Dan Med Bull; 1994 Jun; 41(3):366-70. PubMed ID: 7924465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary hemochromatosis.
    Walker EM; Wolfe MD; Norton ML; Walker SM; Jones MM
    Ann Clin Lab Sci; 1998; 28(5):300-12. PubMed ID: 9784832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary hemochromatosis: etiologic, pathologic, and clinical aspects.
    Bothwell TH; MacPhail AP
    Semin Hematol; 1998 Jan; 35(1):55-71. PubMed ID: 9460809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemochromatosis gene mutations, liver function tests and iron status in alcohol-dependent patients admitted for detoxification.
    Robinson G; Narasimhan S; Weatherall M; Beasley R
    J Gastroenterol Hepatol; 2007 Jun; 22(6):852-4. PubMed ID: 17565641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Searching for hereditary hemochromatosis.
    Laudicina RJ
    Clin Lab Sci; 2006; 19(3):174-83. PubMed ID: 16910235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative impact of HLA phenotype and CD4-CD8 ratios on the clinical expression of hemochromatosis.
    Porto G; Vicente C; Teixeira MA; Martins O; Cabeda JM; Lacerda R; Goncalves C; Fraga J; Macedo G; Silva BM; Alves H; Justiça B; de Sousa M
    Hepatology; 1997 Feb; 25(2):397-402. PubMed ID: 9021953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and phenotypic expression of hemochromatosis in Canadians.
    Borwein ST; Ghent CN; Flanagan PR; Chamberlain MJ; Valberg LS
    Clin Invest Med; 1983; 6(3):171-9. PubMed ID: 6652983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for hemochromatosis: phenotype versus genotype.
    Edwards CQ; Griffen LM; Ajioka RS; Kushner JP
    Semin Hematol; 1998 Jan; 35(1):72-6. PubMed ID: 9460810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic hemochromatosis: importance of population screening?].
    Cartabellotta A; Montalto G
    Recenti Prog Med; 1996 Mar; 87(3):118-23. PubMed ID: 8650432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis.
    Adams PC; Deugnier Y; Moirand R; Brissot P
    Hepatology; 1997 Jan; 25(1):162-6. PubMed ID: 8985284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of silent liver fibrosis in hemochromatosis C282Y homozygotes with normal transaminase levels.
    Beaton M; Adams PC
    Clin Gastroenterol Hepatol; 2008 Jun; 6(6):713-4. PubMed ID: 18550006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemochromatosis and dietary iron supplementation: implications from US mortality, morbidity, and health survey data.
    Gable CB
    J Am Diet Assoc; 1992 Feb; 92(2):208-12. PubMed ID: 1737903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and family studies in genetic hemochromatosis: microsatellite and HFE studies in five atypical families.
    Adams PC; Campion ML; Gandon G; LeGall JY; David V; Jouanolle AM
    Hepatology; 1997 Oct; 26(4):986-90. PubMed ID: 9328324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.